Peripheral Artery Disease Treatment Market to Grow 6.64% Annually

The global market for peripheral artery disease (PAD) treatments, encompassing devices and drugs, was valued at $3.76 billion in 2023. Research firm DelveInsight projects the market to expand at a compound annual growth rate (CAGR) of 6.64% during the forecast period from 2024 to 2030, reaching an estimated $5.47 billion by the end of the decade.

Key drivers for this growth include the increasing prevalence and burden of PAD and arteriosclerosis, alongside a rising global elderly population. Factors such as the growing incidence of obesity, diabetes, and high blood pressure, coupled with an increasing demand for minimally invasive procedures, are also contributing to market expansion.

Within the treatment type segment, angioplasty balloons, a type of device, are expected to capture a significant revenue share. This is attributed to their inherent properties, technical advantages, and ongoing product development, including collaborations and regulatory approvals.

However, the market growth may face constraints due to the high cost associated with various treatment devices and potential adverse events linked to treatments. The report covers the global market, including North America, Europe, the Asia-Pacific region, and the rest of the world.